A prospective, randomized study comparing the effects of preservative-free latanoprost and preserved latanoprost eyedrops on MMP-9 expression and ocular surface disease index in glaucoma patients
Japanese Journal of Ophthalmology · 2026
DOI: 10.1007/s10384-026-01335-2 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Japanese Journal of Ophthalmology, 2026. Verfasst von Edward Kang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Latanoprost, Matrix Metalloproteinase 9, Glaucoma, Open-Angle, Intraocular Pressure. Die Arbeit nennt 24 Literaturangaben. Gefördert von: TAEJOON PHARM Co. Ltd., South Korea..
Abstract (Originalsprache)
PURPOSE: To investigate the effect of preservative-containing and preservative-free latanoprost eyedrops on dry eye symptoms and matrix metalloproteinase 9 expression in untreated open-angle glaucoma patients. STUDY DESIGN: Prospective METHODS: Treatment-naïve open-angle glaucoma patients were randomly assigned to either preservative-containing or preservative-free latanoprost groups. The ocular surface disease index score, Schirmer test, tear break up time, corneal staining score, and matrix metalloproteinase 9 expression in tears were prospectively compared before and at 1 and 3 months after drug instillation. RESULTS: Ocular surface disease index score, Schirmer's test, tear break up time, corneal staining score, and matrix metalloproteinase 9 expression levels did not significantly differ between the two groups before drug instillation. After 3 months, the preservative-free latanoprost group exhibited a significantly longer tear break up time and improved corneal staining score. The proportion of patients with positive matrix metalloproteinase 9 in tears was lower in the preservative-free group, although this difference was not statistically significant (75.0% vs. 62.5%, P = 0.118). CONCLUSION: Compared with preservative-containing latanoprost, the preservative-free preparation led to improved tear break up time and a potential reduction in positive matrix metalloproteinase 9 expression after 3 months in untreated open-angle glaucoma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea.
- Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea. jennypark8321@gmail.com.
- Department of Ophthalmology, Korea University Ansan Hospital, 123 Jeokgeum-ro, Danwon-gu, Ansan-si, 15355, Gyeonggi-do, Korea. jennypark8321@gmail.com.
- Kim's Eye Hospital, Yeongshin-ro 136, Yeongdeungpo-gu, Seoul, 07301, South Korea.
Förderung
- TAEJOON PHARM Co. Ltd., South Korea.
Zitieren
APA
Kang, E., Park, J. H., Yoo, C., & Kim, Y. Y. (2026). A prospective, randomized study comparing the effects of preservative-free latanoprost and preserved latanoprost eyedrops on MMP-9 expression and ocular surface disease index in glaucoma patients. Japanese Journal of Ophthalmology. https://doi.org/10.1007/s10384-026-01335-2
Vancouver
Kang E, Park JH, Yoo C, Kim YY. A prospective, randomized study comparing the effects of preservative-free latanoprost and preserved latanoprost eyedrops on MMP-9 expression and ocular surface disease index in glaucoma patients. Japanese Journal of Ophthalmology. 2026. doi:10.1007/s10384-026-01335-2
BibTeX
@article{Kang2026,
author = {Kang, Edward and Park, Ji-Hye and Yoo, Chungkwon and Kim, Yong Yeon},
title = {A prospective, randomized study comparing the effects of preservative-free latanoprost and preserved latanoprost eyedrops on MMP-9 expression and ocular surface disease index in glaucoma patients},
journal = {Japanese Journal of Ophthalmology},
year = {2026},
doi = {10.1007/s10384-026-01335-2}
}
EUVIMED